1. Home
  2. GBIO vs NWGL Comparison

GBIO vs NWGL Comparison

Compare GBIO & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • NWGL
  • Stock Information
  • Founded
  • GBIO 2016
  • NWGL 2008
  • Country
  • GBIO United States
  • NWGL Macau
  • Employees
  • GBIO N/A
  • NWGL N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • NWGL
  • Sector
  • GBIO Health Care
  • NWGL
  • Exchange
  • GBIO Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • GBIO 29.2M
  • NWGL 26.2M
  • IPO Year
  • GBIO 2020
  • NWGL 2023
  • Fundamental
  • Price
  • GBIO $0.33
  • NWGL $1.06
  • Analyst Decision
  • GBIO Strong Buy
  • NWGL
  • Analyst Count
  • GBIO 4
  • NWGL 0
  • Target Price
  • GBIO $7.33
  • NWGL N/A
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • NWGL 837.1K
  • Earning Date
  • GBIO 08-06-2025
  • NWGL 07-15-2025
  • Dividend Yield
  • GBIO N/A
  • NWGL N/A
  • EPS Growth
  • GBIO N/A
  • NWGL N/A
  • EPS
  • GBIO N/A
  • NWGL N/A
  • Revenue
  • GBIO $24,556,000.00
  • NWGL $21,539,347.00
  • Revenue This Year
  • GBIO N/A
  • NWGL N/A
  • Revenue Next Year
  • GBIO N/A
  • NWGL N/A
  • P/E Ratio
  • GBIO N/A
  • NWGL N/A
  • Revenue Growth
  • GBIO 146.47
  • NWGL N/A
  • 52 Week Low
  • GBIO $0.30
  • NWGL $0.91
  • 52 Week High
  • GBIO $3.65
  • NWGL $6.61
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 42.78
  • NWGL 45.29
  • Support Level
  • GBIO $0.31
  • NWGL $0.91
  • Resistance Level
  • GBIO $0.36
  • NWGL $1.21
  • Average True Range (ATR)
  • GBIO 0.03
  • NWGL 0.58
  • MACD
  • GBIO -0.00
  • NWGL -0.11
  • Stochastic Oscillator
  • GBIO 27.27
  • NWGL 2.63

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: